<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
    <channel>
        <title>Circulation via MedWorm.com</title>
        <description>MedWorm.com provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest items from the 'Circulation' source.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=Circulation&t=Circulation&s=Search&f=source]]></link>
        <lastBuildDate>Wed, 08 Feb 2012 09:32:33 +0100</lastBuildDate>
        <item>
            <title>Blockade of the NF-κB Pathway in the EndotheliumPrevents Insulin Resistance and Prolongs Lifespans.</title>
            <link>http://www.medworm.com/index.php?rid=5661093&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22302838%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: The endothelium plays important roles in obesity- and age-related disorders through intracellular NF-κB signaling, thereby, ultimately, impacting lifespan. Endothelial NF-κB signaling is a potential target for treating the metabolic syndrome as well as for anti-aging strategies.
    PMID: 22302838 [PubMed - as supplied by publisher] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5661093</comments>
            <pubDate>Wed, 01 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5661093</guid>        </item>
        <item>
            <title>Endothelial NF-κB in Obesity and Aging: Is Endothelial NF-κB a Master Regulator of Inflammation and Insulin Resistance?</title>
            <link>http://www.medworm.com/index.php?rid=5661089&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22302839%26dopt%3DAbstract</link>
            <description>Authors: Kim JK
    Abstract
    Insulin resistance is a major characteristic of type 2 diabetes and develops in multiple organs including skeletal muscle, liver, adipose tissue, and heart(1). Insulin resistance is caused by obesity and therefore establishes an important causal relationship between obesity and type 2 diabetes(2). Insulin resistance also develops in aging, but this process is less well understood. Obesity is a complex physiological state with alterations in lipid metabolism, dysregulated production of hormones, ectopic accumulation of fat, mitochondrial dysfunction, and chronic low-grade inflammation(3,4). All of these abnormalities may independently cause insulin resistance and affect glucose homeostasis, which make insulin resistance as equally complex as obesity itself. ...</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5661089</comments>
            <pubDate>Wed, 01 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5661089</guid>        </item>
        <item>
            <title>Very Late Coronary Stent Thrombosis of a Newer Generation Everolimus-Eluting Stent Compared with Early Generation Drug-Eluting Stents: A Prospective Cohort Study.</title>
            <link>http://www.medworm.com/index.php?rid=5661088&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22302840%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: Current treatment with EES is associated with lower risk of VLST compared with early generation DES.
    PMID: 22302840 [PubMed - as supplied by publisher] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5661088</comments>
            <pubDate>Wed, 01 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5661088</guid>        </item>
        <item>
            <title>Evidence of Safety and Effectiveness for a Drug-Eluting Stent: How Should We Respond this Time?</title>
            <link>http://www.medworm.com/index.php?rid=5661087&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22302841%26dopt%3DAbstract</link>
            <description>Authors: Cutlip DE
    Abstract
    Drug-eluting stents (DES) were introduced to the coronary artery disease treatment market in 2003 with much exuberance and fanfare. With over 70% reduction in restenosis and no apparent safety concerns in one year reports from large randomized clinical trials,(1,2) the opportunity for expansion of the technology seemed limitless. Interventional cardiologists responded with confidence and quickly expanded use to a wide array of &quot;off-label&quot; indications, limited only by initial inventory constraints.(3,4) Some even considered DES as a potential therapy for vulnerable lesions or regions that were not yet hemodynamically significant, and there were concerns by hospitals and others that widespread use of these devices for treatment of traditional surgical dise...</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5661087</comments>
            <pubDate>Wed, 01 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5661087</guid>        </item>
        <item>
            <title>Rheb is a Critical Regulator of Autophagy during Myocardial Ischemia: Pathophysiological Implications in Obesity and Metabolic Syndrome.</title>
            <link>http://www.medworm.com/index.php?rid=5661131&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22294621%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: Inactivation of Rheb protects CMs during ED through activation of autophagy. Rheb and mTORC1 may represent therapeutic targets to reduce myocardial damage during ischemia, particularly in obese patients.
    PMID: 22294621 [PubMed - as supplied by publisher] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5661131</comments>
            <pubDate>Tue, 31 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5661131</guid>        </item>
        <item>
            <title>Quality measurement and improvement in the cardiac catheterization laboratory.</title>
            <link>http://www.medworm.com/index.php?rid=5661130&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22294706%26dopt%3DAbstract</link>
            <description>Authors: Frey P, Connors A, Resnic FS
    PMID: 22294706 [PubMed - in process] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5661130</comments>
            <pubDate>Tue, 31 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5661130</guid>        </item>
        <item>
            <title>Epidemiology and genetics of sudden cardiac death.</title>
            <link>http://www.medworm.com/index.php?rid=5661129&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22294707%26dopt%3DAbstract</link>
            <description>Authors: Deo R, Albert CM
    PMID: 22294707 [PubMed - in process] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5661129</comments>
            <pubDate>Tue, 31 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5661129</guid>        </item>
        <item>
            <title>Personalized cardiovascular medicine and drug development: time for a new paradigm.</title>
            <link>http://www.medworm.com/index.php?rid=5661128&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22294708%26dopt%3DAbstract</link>
            <description>Authors: Loscalzo J
    PMID: 22294708 [PubMed - in process] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5661128</comments>
            <pubDate>Tue, 31 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5661128</guid>        </item>
        <item>
            <title>Electrical heart activity recorded during prolonged avalanche burial.</title>
            <link>http://www.medworm.com/index.php?rid=5661127&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22294709%26dopt%3DAbstract</link>
            <description>Authors: Strapazzon G, Beikircher W, Procter E, Brugger H
    PMID: 22294709 [PubMed - in process] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5661127</comments>
            <pubDate>Tue, 31 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5661127</guid>        </item>
        <item>
            <title>Spontaneous fontan physiology in burnt-out endomyocardial fibrosis.</title>
            <link>http://www.medworm.com/index.php?rid=5661115&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22294710%26dopt%3DAbstract</link>
            <description>Authors: Narayan GS, Sivasubramonian S
    PMID: 22294710 [PubMed - in process] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5661115</comments>
            <pubDate>Tue, 31 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5661115</guid>        </item>
        <item>
            <title>Circulation Editors' Picks: Most Read Articles on the Topic of Biomarkers.</title>
            <link>http://www.medworm.com/index.php?rid=5661100&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22294711%26dopt%3DAbstract</link>
            <description>Authors:  
    Abstract
    The following articles are being highlighted as part of Circulation's Topic Review series. This series will summarize the most important manuscripts, as selected by the editors, published in Circulation and the Circulation subspecialty journals. The studies included in this article represent the most read manuscripts published on the topic of biomarkers in 2010 and 2011.
    PMID: 22294711 [PubMed - as supplied by publisher] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5661100</comments>
            <pubDate>Tue, 31 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5661100</guid>        </item>
        <item>
            <title>Letter by lecoultre and tam regarding article, &quot;increased adipose tissue oxygen tension in obese compared with lean men is accompanied by insulin resistance, impaired adipose tissue capillarization, and inflammation&quot;.</title>
            <link>http://www.medworm.com/index.php?rid=5661099&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22294712%26dopt%3DAbstract</link>
            <description>Letter by lecoultre and tam regarding article, &quot;increased adipose tissue oxygen tension in obese compared with lean men is accompanied by insulin resistance, impaired adipose tissue capillarization, and inflammation&quot;.
    Circulation. 2012 Jan 31;125(4):e315
    Authors: Lecoultre V, Tam CS
    PMID: 22294712 [PubMed - in process] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5661099</comments>
            <pubDate>Tue, 31 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5661099</guid>        </item>
        <item>
            <title>Letter by karam and marijon regarding article, &quot;atrial fibrillation: outpatient presentation and management&quot;.</title>
            <link>http://www.medworm.com/index.php?rid=5661098&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22294713%26dopt%3DAbstract</link>
            <description>Letter by karam and marijon regarding article, &quot;atrial fibrillation: outpatient presentation and management&quot;.
    Circulation. 2012 Jan 31;125(4):e317
    Authors: Karam N, Marijon E
    PMID: 22294713 [PubMed - in process] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5661098</comments>
            <pubDate>Tue, 31 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5661098</guid>        </item>
        <item>
            <title>Letter by montone et Al regarding article, &quot;atrial fibrillation: outpatient presentation and management&quot;.</title>
            <link>http://www.medworm.com/index.php?rid=5661095&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22294714%26dopt%3DAbstract</link>
            <description>Letter by montone et Al regarding article, &quot;atrial fibrillation: outpatient presentation and management&quot;.
    Circulation. 2012 Jan 31;125(4):e318
    Authors: Montone RA, Mollo R, Nerla R
    PMID: 22294714 [PubMed - in process] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5661095</comments>
            <pubDate>Tue, 31 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5661095</guid>        </item>
        <item>
            <title>Letter by Madias Regarding the Article, &quot;Repolarization Alternans Reveals Vulnerability to Human Atrial fibrillation&quot;.</title>
            <link>http://www.medworm.com/index.php?rid=5661094&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22294715%26dopt%3DAbstract</link>
            <description>Letter by Madias Regarding the Article, &quot;Repolarization Alternans Reveals Vulnerability to Human Atrial fibrillation&quot;.
    Circulation. 2012 Jan 31;125(4):e320
    Authors: Madias JE
    PMID: 22294715 [PubMed - in process] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5661094</comments>
            <pubDate>Tue, 31 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5661094</guid>        </item>
        <item>
            <title>Empiric Support for Cardiovascular Health: The Case Gets Even Stronger.</title>
            <link>http://www.medworm.com/index.php?rid=5661135&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22291125%26dopt%3DAbstract</link>
            <description>Authors: Appel LJ
    Abstract
    Recently, the American Heart Association (AHA) adopted a new and ambitious strategic goal - &quot;by 2020, to improve the cardiovascular health of all Americans by 20% while reducing deaths from cardiovascular disease by 20%&quot;(1). In the process, it defined a new concept, cardiovascular health, which is comprised of 7 components: 4 ideal health behaviors (nonsmoking, body mass index &amp;lt; 25 kg/m(2), physical activity at goal levels, and a diet consistent with current recommendations) together with 3 ideal health factors (untreated total cholesterol &amp;lt; 200mg/dL, untreated blood pressure &amp;lt;120/&amp;lt;80 mm Hg, and fasting blood glucose&amp;lt;100 mg/dL). This new approach emphasizes prevention with a focus on achieving and sustaining desirable behaviors. At the time...</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5661135</comments>
            <pubDate>Mon, 30 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5661135</guid>        </item>
        <item>
            <title>Ideal Cardiovascular Health and Mortality from All Causes and Diseases of the Circulatory System among Adults in the United States.</title>
            <link>http://www.medworm.com/index.php?rid=5661134&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22291126%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: The number of ideal cardiovascular health metrics is a strong predictor of mortality from all-causes and diseases of the circulatory system.
    PMID: 22291126 [PubMed - as supplied by publisher] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5661134</comments>
            <pubDate>Mon, 30 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5661134</guid>        </item>
        <item>
            <title>Healthy Lifestyle through Young Adulthood and Presence of Low Cardiovascular Disease Risk Profile in Middle Age.</title>
            <link>http://www.medworm.com/index.php?rid=5661133&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22291127%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: Maintaining a healthy lifestyle throughout young adulthood is strongly associated with low CVD risk profile in middle age. Public health and individual efforts are needed to improve adoption and maintenance of healthy lifestyles in young adults.
    PMID: 22291127 [PubMed - as supplied by publisher] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5661133</comments>
            <pubDate>Mon, 30 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5661133</guid>        </item>
        <item>
            <title>Increasing Referral and Participation Rates to Outpatient Cardiac Rehabilitation: The Valuable Role of Healthcare Professionals in the Inpatient and Home Health Settings: A Science Advisory From the American Heart Association.</title>
            <link>http://www.medworm.com/index.php?rid=5661132&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22291128%26dopt%3DAbstract</link>
            <description>Authors: Arena R, Williams M, Forman DE, Cahalin LP, Coke L, Myers J, Hamm L, Kris-Etherton P, Humphrey R, Bittner V, Lavie CJ, 
    PMID: 22291128 [PubMed - as supplied by publisher] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5661132</comments>
            <pubDate>Mon, 30 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5661132</guid>        </item>
        <item>
            <title>Trends in Use of Implantable Cardioverter Defibrillator Therapy Among Patients Hospitalized for Heart Failure: Have the Previously Observed Sex and Racial Disparities Changed Over Time?</title>
            <link>http://www.medworm.com/index.php?rid=5661136&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22287589%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: In the GWTG-HF quality improvement program, a significant increase in ICD therapy use was observed over time in all sex and race groups. The previously described racial disparities in ICD use were no longer present by the end of the study period; however, sex differences persisted.
    PMID: 22287589 [PubMed - as supplied by publisher] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5661136</comments>
            <pubDate>Fri, 27 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5661136</guid>        </item>
        <item>
            <title>Percutaneous Coronary Intervention in Patients with Severe Aortic Stenosis: Implications for Transcatheter Aortic Valve Replacement.</title>
            <link>http://www.medworm.com/index.php?rid=5643065&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22282327%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: PCI can be performed in patients with severe symptomatic AS and CAD without an increased risk of short term mortality compared to propensity matched patients without AS. Patients with EF ≤30% and STS score ≥10% are at a highest risk of 30-day mortality after PCI. This finding has significant implications in the management of severe CAD in high risk severe symptomatic AS patients being considered for TAVR.
    PMID: 22282327 [PubMed - as supplied by publisher] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5643065</comments>
            <pubDate>Thu, 26 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5643065</guid>        </item>
        <item>
            <title>CAD and Aortic Stenosis in the TAVR Era: Old Questions, New Paradigms. The Evolving Role of PCI in the Treatment of Patients with Aortic Stenosis.</title>
            <link>http://www.medworm.com/index.php?rid=5643064&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22282328%26dopt%3DAbstract</link>
            <description>Authors: Kodali SK, Moses JW
    Abstract
    Significant coronary artery disease (CAD) is present in up to 50% of patients with symptomatic aortic stenosis (AS). The standard treatment has been coronary artery bypass grafting at the time of surgical aortic valve replacement (AVR). While numerous databases have shown that the addition of bypass grafting to an AVR nearly doubles the mortality, surgical series have shown that leaving significant coronary stenosis untreated increases AVR mortality(1-4). Thus the standard of care for this population has been concomitant coronary artery bypass grafting along with surgical aortic valve replacement. (SELECT FULL TEXT TO CONTINUE).
    PMID: 22282328 [PubMed - as supplied by publisher] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5643064</comments>
            <pubDate>Thu, 26 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5643064</guid>        </item>
        <item>
            <title>Association of Plasma Phospholipid Long-Chain Omega-3 Fatty Acids with Incident Atrial Fibrillation in Older Adults: The Cardiovascular Health Study.</title>
            <link>http://www.medworm.com/index.php?rid=5643063&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22282329%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: In older adults, higher circulating total long-chain n-3 PUFA and DHA levels were associated with lower risk of incident AF. These results highlight the need to evaluate whether increased dietary intake of these fatty acids could be effective for primary prevention of AF.
    PMID: 22282329 [PubMed - as supplied by publisher] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5643063</comments>
            <pubDate>Thu, 26 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5643063</guid>        </item>
        <item>
            <title>Role of substrate and triggers in the genesis of cardiac alternans, from the myocyte to the whole heart: implications for therapy.</title>
            <link>http://www.medworm.com/index.php?rid=5643080&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22271847%26dopt%3DAbstract</link>
            <description>Authors: Merchant FM, Armoundas AA
    PMID: 22271847 [PubMed - in process] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5643080</comments>
            <pubDate>Tue, 24 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5643080</guid>        </item>
        <item>
            <title>Overview of the 2011 Food and Drug Administration Circulatory System Devices Panel of the Medical Devices Advisory Committee Meeting on the Edwards SAPIEN&amp;trade; Transcatheter Heart Valve.</title>
            <link>http://www.medworm.com/index.php?rid=5643079&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22271848%26dopt%3DAbstract</link>
            <description>Authors: Barbash IM, Waksman R
    PMID: 22271848 [PubMed - in process] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5643079</comments>
            <pubDate>Tue, 24 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5643079</guid>        </item>
        <item>
            <title>Cardiac positron-emission tomography images with an amyloid-specific tracer in familial transthyretin-related systemic amyloidosis.</title>
            <link>http://www.medworm.com/index.php?rid=5643078&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22271849%26dopt%3DAbstract</link>
            <description>Authors: Furukawa K, Ikeda S, Okamura N, Tashiro M, Tomita N, Furumoto S, Iwata R, Yanai K, Kudo Y, Arai H
    PMID: 22271849 [PubMed - in process] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5643078</comments>
            <pubDate>Tue, 24 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5643078</guid>        </item>
        <item>
            <title>Introduction to noninvasive cardiac imaging.</title>
            <link>http://www.medworm.com/index.php?rid=5643077&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22271850%26dopt%3DAbstract</link>
            <description>Authors: Blankstein R
    PMID: 22271850 [PubMed - in process] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5643077</comments>
            <pubDate>Tue, 24 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5643077</guid>        </item>
        <item>
            <title>A case of a double valve.</title>
            <link>http://www.medworm.com/index.php?rid=5643076&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22271851%26dopt%3DAbstract</link>
            <description>Authors: Atashband A, Ramasubbu K
    PMID: 22271851 [PubMed - in process] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5643076</comments>
            <pubDate>Tue, 24 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5643076</guid>        </item>
        <item>
            <title>Circulation Editors' Picks: Most Read Articles on Studies Performed in an Animal Model.</title>
            <link>http://www.medworm.com/index.php?rid=5643075&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22271852%26dopt%3DAbstract</link>
            <description>Authors:  
    Abstract
    The following articles are being highlighted as part of Circulation's Topic Review series. This series will summarize the most important manuscripts, as selected by the editors, published in Circulation and the Circulation subspecialty journals. The studies included in this article represent the most read of those performed in an animal model.
    PMID: 22271852 [PubMed - as supplied by publisher] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5643075</comments>
            <pubDate>Tue, 24 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5643075</guid>        </item>
        <item>
            <title>Letter by cornet et Al regarding article, &quot;relationship between supranormal oxygen tension and outcome after resuscitation from cardiac arrest&quot;.</title>
            <link>http://www.medworm.com/index.php?rid=5643074&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22271853%26dopt%3DAbstract</link>
            <description>Letter by cornet et Al regarding article, &quot;relationship between supranormal oxygen tension and outcome after resuscitation from cardiac arrest&quot;.
    Circulation. 2012 Jan 24;125(3):e287
    Authors: Cornet AD, Peters MJ, Kooter AJ
    PMID: 22271853 [PubMed - in process] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5643074</comments>
            <pubDate>Tue, 24 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5643074</guid>        </item>
        <item>
            <title>Letter by bellomo et Al regarding article, &quot;relationship between supranormal oxygen tension and outcome after resuscitation from cardiac arrest&quot;.</title>
            <link>http://www.medworm.com/index.php?rid=5643073&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22271854%26dopt%3DAbstract</link>
            <description>Letter by bellomo et Al regarding article, &quot;relationship between supranormal oxygen tension and outcome after resuscitation from cardiac arrest&quot;.
    Circulation. 2012 Jan 24;125(3):e288
    Authors: Bellomo R, Bailey M, Nichol A
    PMID: 22271854 [PubMed - in process] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5643073</comments>
            <pubDate>Tue, 24 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5643073</guid>        </item>
        <item>
            <title>Reply to letters regarding article, &quot;relationship between supranormal oxygen tension and outcome after resuscitation from cardiac arrest&quot;.</title>
            <link>http://www.medworm.com/index.php?rid=5643072&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22271855%26dopt%3DAbstract</link>
            <description>Reply to letters regarding article, &quot;relationship between supranormal oxygen tension and outcome after resuscitation from cardiac arrest&quot;.
    Circulation. 2012 Jan 24;125(3):e289
    Authors: Kilgannon JH, Trzeciak S, Parrillo JE, Dellinger RP, Milcarek B, Hunter K, Jones AE, Shapiro NI
    PMID: 22271855 [PubMed - in process] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5643072</comments>
            <pubDate>Tue, 24 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5643072</guid>        </item>
        <item>
            <title>Letter by Govindarajan and Salgado Regarding Article, &quot;Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation: An Analysis of the Randomized Evaluation of Long-Term Anticoagulant Therapy (RE-LY) Trial&quot;.</title>
            <link>http://www.medworm.com/index.php?rid=5643071&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22271856%26dopt%3DAbstract</link>
            <description>Letter by Govindarajan and Salgado Regarding Article, &quot;Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation: An Analysis of the Randomized Evaluation of Long-Term Anticoagulant Therapy (RE-LY) Trial&quot;.
    Circulation. 2012 Jan 24;125(3):e290
    Authors: Govindarajan R, Salgado E
    PMID: 22271856 [PubMed - in process] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5643071</comments>
            <pubDate>Tue, 24 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5643071</guid>        </item>
        <item>
            <title>Letter by Reynolds et al Regarding Article, &quot;Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation: An Analysis of the Randomized Evaluation of Long-Term Anticoagulant Therapy (RE-LY) Trial&quot;.</title>
            <link>http://www.medworm.com/index.php?rid=5643070&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22271857%26dopt%3DAbstract</link>
            <description>Letter by Reynolds et al Regarding Article, &quot;Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation: An Analysis of the Randomized Evaluation of Long-Term Anticoagulant Therapy (RE-LY) Trial&quot;.
    Circulation. 2012 Jan 24;125(3):e291
    Authors: Reynolds S, Parra D, Rosenstein RS
    PMID: 22271857 [PubMed - in process] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5643070</comments>
            <pubDate>Tue, 24 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5643070</guid>        </item>
        <item>
            <title>Letter by Reiffel Regarding Article, &quot;Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation: An Analysis of the Randomized Evaluation of Long-Term Anticoagulant Therapy (RE-LY) Trial&quot;.</title>
            <link>http://www.medworm.com/index.php?rid=5643069&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22271858%26dopt%3DAbstract</link>
            <description>Letter by Reiffel Regarding Article, &quot;Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation: An Analysis of the Randomized Evaluation of Long-Term Anticoagulant Therapy (RE-LY) Trial&quot;.
    Circulation. 2012 Jan 24;125(3):e292
    Authors: Reiffel JA
    PMID: 22271858 [PubMed - in process] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5643069</comments>
            <pubDate>Tue, 24 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5643069</guid>        </item>
        <item>
            <title>Reply to Letters Regarding Article, &quot;Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation: An Analysis of the Randomized Evaluation of Long-Term Anticoagulant Therapy (RE-LY) Trial&quot;.</title>
            <link>http://www.medworm.com/index.php?rid=5643068&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22271859%26dopt%3DAbstract</link>
            <description>Reply to Letters Regarding Article, &quot;Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation: An Analysis of the Randomized Evaluation of Long-Term Anticoagulant Therapy (RE-LY) Trial&quot;.
    Circulation. 2012 Jan 24;125(3):e293-4
    Authors: Eikelboom JW, Connolly SJ, Healey JS, Yang S, Yusuf S, Wallentin L, Oldgren J, Ezekowitz M, Alings M, Kaatz S, Hohnloser SH, Diener HC, Franzosi MG, Huber K, Reilly P, Varrone J
    PMID: 22271859 [PubMed - in process] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5643068</comments>
            <pubDate>Tue, 24 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5643068</guid>        </item>
        <item>
            <title>Lymphangiogenesis: A Potential New Therapy for Lymphedema?</title>
            <link>http://www.medworm.com/index.php?rid=5643067&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22275500%26dopt%3DAbstract</link>
            <description>Authors: Cooke JP
    Abstract
    At the level of the capillaries, the systemic circulation loses about 2-4 liters of fluid and about 100g of protein into the interstitium daily. This ultrafiltrate of the systemic capillaries is returned to the circulatory system by the lymphatics. The lymphatic vasculature is highly specialized to perform this service, beginning with the blind-ended lymphatic capillaries. These vessels are highly permeable to protein, fluid and even cells, due to fenestrations in their basement membrane, and discontinuous button-like junctions rather than tight intercellular junctions as observed in the systemic capillaries(1). The lymphatic capillaries merge into collectors and larger lymphatic conduits that are invested with vascular smooth muscle (capable of contracti...</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5643067</comments>
            <pubDate>Tue, 24 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5643067</guid>        </item>
        <item>
            <title>9-Cis Retinoic Acid Promotes Lymphangiogenesis and Enhances Lymphatic Vessel Regeneration: Therapeutic Implications of 9-Cis Retinoic Acid for Secondary Lymphedema.</title>
            <link>http://www.medworm.com/index.php?rid=5643066&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22275501%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: These in vitro and animal studies demonstrate that 9-cisRA potently activates lymphangiogenesis and promotes lymphatic regeneration in an experimental lymphedema model, presenting it as a promising novel therapeutic agent to treat human lymphedema patients.
    PMID: 22275501 [PubMed - as supplied by publisher] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5643066</comments>
            <pubDate>Tue, 24 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5643066</guid>        </item>
        <item>
            <title>Evaluating Parents and Adult Caregivers as &quot;Agents of Change&quot; for Treating Obese Children: Evidence for Parent Behavior Change Strategies and Research Gaps: A Scientific Statement From the American Heart Association.</title>
            <link>http://www.medworm.com/index.php?rid=5643081&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22271754%26dopt%3DAbstract</link>
            <description>Evaluating Parents and Adult Caregivers as &quot;Agents of Change&quot; for Treating Obese Children: Evidence for Parent Behavior Change Strategies and Research Gaps: A Scientific Statement From the American Heart Association.
    Circulation. 2012 Jan 23;
    Authors: Faith MS, Van Horn L, Appel LJ, Burke LE, Carson JA, Franch HA, Jakicic JM, Kral TV, Odoms-Young A, Wansink B, Wylie-Rosett J, 
    Abstract
    This scientific statement addresses parents and adult caregivers (PACs) as &quot;agents of change&quot; for obese children, evaluating the strength of evidence that particular parenting strategies can leverage behavior change and reduce positive energy balance in obese youth. The statement has 3 specific aims. The first is to review core behavior change strategies for PACs as used in family-based treat...</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5643081</comments>
            <pubDate>Mon, 23 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5643081</guid>        </item>
        <item>
            <title>CHOP-10 Limits Postnatal Neovascularization Through the Control of eNOS Gene Expression.</title>
            <link>http://www.medworm.com/index.php?rid=5625452&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22265908%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: This study identifies CHOP-10 as an important transcription factor modulating vessel formation and maturation.
    PMID: 22265908 [PubMed - as supplied by publisher] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5625452</comments>
            <pubDate>Fri, 20 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5625452</guid>        </item>
        <item>
            <title>Coronary Vasospasm Induced in Transgenic Mouse with the Increased Phospholipase C-δ1 Activity.</title>
            <link>http://www.medworm.com/index.php?rid=5625451&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22265909%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: Increased PLC-δ1 activity enhances coronary vasomotility such as seen in patients with CSA.
    PMID: 22265909 [PubMed - as supplied by publisher] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5625451</comments>
            <pubDate>Fri, 20 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5625451</guid>        </item>
        <item>
            <title>Sexual Activity and Cardiovascular Disease: A Scientific Statement From the American Heart Association.</title>
            <link>http://www.medworm.com/index.php?rid=5625450&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22267844%26dopt%3DAbstract</link>
            <description>Authors: Levine GN, Steinke EE, Bakaeen FG, Bozkurt B, Cheitlin MD, Conti JB, Foster E, Jaarsma T, Kloner RA, Lange RA, Lindau ST, Maron BJ, Moser DK, Ohman EM, Seftel AD, Stewart WJ, 
    PMID: 22267844 [PubMed - as supplied by publisher] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5625450</comments>
            <pubDate>Thu, 19 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5625450</guid>        </item>
        <item>
            <title>Angiogenic Factors and the Risk of Adverse Outcomes in Women with Suspected Preeclampsia.</title>
            <link>http://www.medworm.com/index.php?rid=5625461&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22261192%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: In women with suspected preeclampsia presenting at &amp;lt;34 weeks, circulating sFlt1/PlGF ratio predicts adverse outcomes occurring within two weeks. The accuracy of this test is substantially better than current approaches and may be useful in risk stratification and management. Additional studies are warranted to validate these findings.
    PMID: 22261192 [PubMed - as supplied by publisher] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5625461</comments>
            <pubDate>Wed, 18 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5625461</guid>        </item>
        <item>
            <title>Extracellular Matrix Proteomics in Cardiac Ischemia/Reperfusion: The Search is On.</title>
            <link>http://www.medworm.com/index.php?rid=5625460&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22261193%26dopt%3DAbstract</link>
            <description>Authors: Deleon KY, de Castro Brás L, Lange RA, Lindsey ML
    Abstract
    Prolonged myocardial ischemia leads to myocytenecrosis, which initiates a localized inflammatory response that catabolizes the cellular debris and initiates deposition of extracellular matrix (ECM) proteins.(1) In addition to providing a vital structural framework for the three-dimensional organization of cells, the ECM determines the physical properties of biological tissues and acts as a dynamic microenvironment for cellular signaling. A number of cardiac diseases, including myocardial ischemia and reperfusion (I/R), are associated with qualitative and quantitative alterations in ECM proteins.(2) Understanding ECM changes is important for identifying factors that tip the balance between favorable reparative remo...</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5625460</comments>
            <pubDate>Wed, 18 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5625460</guid>        </item>
        <item>
            <title>Proteomics Analysis of Cardiac Extracellular Matrix Remodeling in a Porcine Model of Ischemia-Reperfusion Injury.</title>
            <link>http://www.medworm.com/index.php?rid=5625459&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22261194%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: Our findings reveal a bio-signature of early and late stage ECM remodeling after myocardial ischemia-reperfusion injury, which may have clinical utility as prognostic markers and modifiable targets for drug discovery.
    PMID: 22261194 [PubMed - as supplied by publisher] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5625459</comments>
            <pubDate>Wed, 18 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5625459</guid>        </item>
        <item>
            <title>Gene Inactivation of PCSK9 Reduces Atherosclerosis in Mice.</title>
            <link>http://www.medworm.com/index.php?rid=5625458&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22261195%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: Altogether, our results show a direct relationship between PCSK9 and atherosclerosis. PCSK9 overexpression is pro-atherogenic, while its absence is protective.
    PMID: 22261195 [PubMed - as supplied by publisher] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5625458</comments>
            <pubDate>Wed, 18 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5625458</guid>        </item>
        <item>
            <title>Human Embryonic and Induced Pluripotent Stem Cells-Derived Cardiomyocytes Exhibit Beat Rate Variability and Power-Law Behavior.</title>
            <link>http://www.medworm.com/index.php?rid=5625457&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22261196%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: Collectively, this is the first study demonstrating that hESC-CMs and iPSC-CMs exhibit BRV andpower law behavior as in humans, thus supporting the potential capability of these cell sources to serve as biological pacemakers.Our ability to generate sinoatrial-compatible spontaneous cardiomyocytes from the patient's own hair (via keratinocytes-derived iPSC), thus eliminating the critical need for immunosuppression, renders these myocytes an attractive cell source as biological pacemakers.
    PMID: 22261196 [PubMed - as supplied by publisher] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5625457</comments>
            <pubDate>Wed, 18 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5625457</guid>        </item>
        <item>
            <title>Human Biological Pacemakers: Intrinsic Variability and Stability.</title>
            <link>http://www.medworm.com/index.php?rid=5625456&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22261197%26dopt%3DAbstract</link>
            <description>Authors: Ripplinger CM, Bers DM
    Abstract
    In healthy individuals, the sinoatrial node (SAN) is responsible for initiating excitation over 100,000 times per day. As with all cardiac pacemaking cells in the specialized conduction system, SAN automaticity is driven by diastolic depolarization via several redundant pathways to ensure that the heart beats. Key cellular mechanisms include the hyperpolarization-activated inward current I(f) and the &quot;Ca Clock&quot; (inward Na/Ca exchange current activated by sarcoplasmic reticulum Ca(2+) release).(1) However, molecular, histological, electrophysiological, and in silico studies have revealed that the SAN is extremely complex and the redundant systems not only provide safety of pacemaking, but also allows for precise modulation of heart rate to ac...</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5625456</comments>
            <pubDate>Wed, 18 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5625456</guid>        </item>
        <item>
            <title>Impact of Progression of Diastolic Dysfunction on Mortality in Patients with Normal Ejection Fraction.</title>
            <link>http://www.medworm.com/index.php?rid=5625455&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22261198%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: In patients with normal baseline LV ejection fraction, worsening of diastolic function is an independent predictor of mortality.
    PMID: 22261198 [PubMed - as supplied by publisher] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5625455</comments>
            <pubDate>Wed, 18 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5625455</guid>        </item>
        <item>
            <title>LV Diastolic Dysfunction and Prognosis.</title>
            <link>http://www.medworm.com/index.php?rid=5625454&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22261199%26dopt%3DAbstract</link>
            <description>Authors: Kitzman DW, Little WC
    Abstract
    To provide for tissue perfusion without pulmonary congestion, the left ventricle (LV) must eject an adequate stroke volume at arterial pressure (systolic function) and fill without requiring an abnormally increased left atrial pressure (diastolic function). Systolic and diastolic function must be adequate to meet the needs of the body both at rest and during stress (reserve capacity). (SELECT FULL TEXT TO CONTINUE).
    PMID: 22261199 [PubMed - as supplied by publisher] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5625454</comments>
            <pubDate>Wed, 18 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5625454</guid>        </item>
        <item>
            <title>Association of Proton Pump Inhibitor Use on Cardiovascular Outcomes with Clopidogrel and Ticagrelor: Insights from PLATO.</title>
            <link>http://www.medworm.com/index.php?rid=5625453&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22261200%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: The use of a PPI was independently associated with a higher rate of CV events in ACS patients receiving clopidogrel. However, a similar association was observed between CV events and PPI use during ticagrelor treatment and with other non-PPI GI treatment. Therefore, in the PLATO trial, the association between PPI use and adverse events may be due to confounding, with PPI use more of a marker for, than a cause of, higher rates of CV events. CLINICAL TRIAL REGISTRATION INFORMATION: http://www.clinicatrials.gov; NCT00391872.
    PMID: 22261200 [PubMed - as supplied by publisher] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5625453</comments>
            <pubDate>Wed, 18 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5625453</guid>        </item>
        <item>
            <title>Antiplatelet therapy and proton pump inhibition: clinician update.</title>
            <link>http://www.medworm.com/index.php?rid=5625467&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22249527%26dopt%3DAbstract</link>
            <description>Authors: Moukarbel GV, Bhatt DL
    PMID: 22249527 [PubMed - in process] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5625467</comments>
            <pubDate>Tue, 17 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5625467</guid>        </item>
        <item>
            <title>Antiarrhythmic drug therapy for atrial fibrillation.</title>
            <link>http://www.medworm.com/index.php?rid=5625466&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22249528%26dopt%3DAbstract</link>
            <description>Authors: Zimetbaum P
    PMID: 22249528 [PubMed - in process] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5625466</comments>
            <pubDate>Tue, 17 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5625466</guid>        </item>
        <item>
            <title>Very late mycotic pseudoaneurysm associated with drug-eluting stent fracture.</title>
            <link>http://www.medworm.com/index.php?rid=5625465&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22249529%26dopt%3DAbstract</link>
            <description>Authors: Del Trigo M, Jimenez-Quevedo P, Fernandez-Golfin C, Vaño E, Delgado-Bolton R, Alfonso F, Gonzalo N, Kallmeyer A, Montes L, Escribano N, Hernandez-Antolin R, Macaya C
    PMID: 22249529 [PubMed - in process] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5625465</comments>
            <pubDate>Tue, 17 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5625465</guid>        </item>
        <item>
            <title>Multimodality imaging of coronary-subclavian-vertebral steal syndrome.</title>
            <link>http://www.medworm.com/index.php?rid=5625464&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22249530%26dopt%3DAbstract</link>
            <description>Authors: Karakulak UN, Kose IC, Evranos B, Okutucu S, Hazirolan T, Aytemir K, Oto A
    PMID: 22249530 [PubMed - in process] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5625464</comments>
            <pubDate>Tue, 17 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5625464</guid>        </item>
        <item>
            <title>Myocardial deformation imaging: current status and future directions.</title>
            <link>http://www.medworm.com/index.php?rid=5625463&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22249531%26dopt%3DAbstract</link>
            <description>Authors: Shah AM, Solomon SD
    PMID: 22249531 [PubMed - in process] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5625463</comments>
            <pubDate>Tue, 17 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5625463</guid>        </item>
        <item>
            <title>Circulation Editors' Picks: Most Read Articles in Atherosclerosis.</title>
            <link>http://www.medworm.com/index.php?rid=5625462&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22249532%26dopt%3DAbstract</link>
            <description>Authors:  
    Abstract
    The following articles are being highlighted as part of Circulation's Topic Review series. This series will summarize the most important manuscripts, as selected by the editors, published in Circulation and the Circulation subspecialty journals. The studies included in this article represent the most read manuscripts published on the topic of atherosclerosis in 2010 and 2011.
    PMID: 22249532 [PubMed - as supplied by publisher] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5625462</comments>
            <pubDate>Tue, 17 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5625462</guid>        </item>
        <item>
            <title>Gremlin Plays a Key Role in the Pathogenesis of Pulmonary Hypertension.</title>
            <link>http://www.medworm.com/index.php?rid=5625468&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22247494%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: These findings demonstrate a central role for increased gremlin in hypoxia-induced pulmonary vascular remodeling and the increased pulmonary vascular resistance in hypoxic pulmonary hypertension. High levels of basal gremlin expression in the lung may account for the unique vulnerability of the pulmonary circulation to heterozygous mutations of BMPR2 in pulmonary arterial hypertension.
    PMID: 22247494 [PubMed - as supplied by publisher] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5625468</comments>
            <pubDate>Fri, 13 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5625468</guid>        </item>
        <item>
            <title>Metabolic Syndrome in Adolescence: Can it be Predicted from Natal and Parental Profile? The Prediction of Metabolic Syndrome in Adolescence (PREMA) Study.</title>
            <link>http://www.medworm.com/index.php?rid=5625470&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22247492%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: The co-existence of low birth weight, small head circumference and parental history of overweight or obesity may be useful for detection of children at risk of developing MetS in adolescence.
    PMID: 22247492 [PubMed - as supplied by publisher] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5625470</comments>
            <pubDate>Thu, 12 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5625470</guid>        </item>
        <item>
            <title>White Matter Protection in Congenital Heart Surgery.</title>
            <link>http://www.medworm.com/index.php?rid=5625469&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22247493%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: Primary repair in neonates and young infants potentially provides successful WM development in CHD patients. Cardiac surgery during this susceptible period should avoid ischemia-reperfusion injury and minimize inflammation to prevent long-term WM-related neurological impairment.
    PMID: 22247493 [PubMed - as supplied by publisher] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5625469</comments>
            <pubDate>Thu, 12 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5625469</guid>        </item>
        <item>
            <title>Relationship Between Vein Graft Failure and Subsequent Clinical Outcomes Following Coronary Artery Bypass Surgery.</title>
            <link>http://www.medworm.com/index.php?rid=5625472&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22238227%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: VGF is common after CABG surgery and is associated with repeat revascularization, but not with death and/or MI. Further investigations are needed to evaluate therapies and strategies for decreasing VGF to improve outcomes in patients undergoing CABG surgery.
    PMID: 22238227 [PubMed - as supplied by publisher] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5625472</comments>
            <pubDate>Wed, 11 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5625472</guid>        </item>
        <item>
            <title>Long-Term Propensity-Score Matched Comparison of Percutaneous Closure of Patent Foramen Ovale with Medical Treatment after Paradoxical Embolism.</title>
            <link>http://www.medworm.com/index.php?rid=5625471&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22238228%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: In this long-term observational, propensity score matched study, percutaneous PFO closure was more effective than medical treatment for secondary prevention of recurrent cerebrovascular events among patients with PFO related TIA or stroke.
    PMID: 22238228 [PubMed - as supplied by publisher] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5625471</comments>
            <pubDate>Wed, 11 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5625471</guid>        </item>
        <item>
            <title>Risk of Acute Myocardial Infarction after Death of a Significant Person in One's Life: The Determinants of MI Onset Study.</title>
            <link>http://www.medworm.com/index.php?rid=5579483&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22230481%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: Grief over the death of a significant person was associated with an acutely increased risk of MI in the subsequent days. The impact may be greatest among individuals at high cardiovascular risk.
    PMID: 22230481 [PubMed - as supplied by publisher] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5579483</comments>
            <pubDate>Mon, 09 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5579483</guid>        </item>
        <item>
            <title>Emergency Medical Service Dispatch Cardiopulmonary Resuscitation Prearrival Instructions to Improve Survival From Out-of-Hospital Cardiac Arrest: A Scientific Statement From the American Heart Association.</title>
            <link>http://www.medworm.com/index.php?rid=5579482&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22230482%26dopt%3DAbstract</link>
            <description>Authors: Lerner EB, Rea TD, Bobrow BJ, Acker JE, Berg RA, Brooks SC, Cone DC, Gay M, Gent LM, Mears G, Nadkarni VM, O'Connor RE, Potts J, Sayre MR, Swor RA, Travers AH, 
    PMID: 22230482 [PubMed - as supplied by publisher] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5579482</comments>
            <pubDate>Mon, 09 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5579482</guid>        </item>
        <item>
            <title>Phospholipase A2 Enzymes, High-Dose Atorvastatin, and Prediction of Ischemic Events Following Acute Coronary Syndromes.</title>
            <link>http://www.medworm.com/index.php?rid=5579481&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22230483%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: sPLA(2) mass independently predicts death during a 16 week period following ACS. High dose atorvastatin significantly reduces sPLA(2) and Lp-PLA(2) mass and activity after ACS and mitigates the risk of death associated with sPLA(2) mass. Atorvastatin may exert anti-inflammatory effects on phospholipases that contribute to its therapeutic benefit after ACS.
    PMID: 22230483 [PubMed - as supplied by publisher] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5579481</comments>
            <pubDate>Mon, 09 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5579481</guid>        </item>
        <item>
            <title>Retrospective Analysis of Surgery Versus Endovascular Intervention in Takayasu Arteritis: A Multicenter Experience.</title>
            <link>http://www.medworm.com/index.php?rid=5579480&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22230484%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: The overall 5-years arterial complication rate was of 44%. Biological inflammation increased the likelihood of complications after revascularization in patients with TA.
    PMID: 22230484 [PubMed - as supplied by publisher] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5579480</comments>
            <pubDate>Mon, 09 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5579480</guid>        </item>
        <item>
            <title>The Bispecific SDF1-GPVI Fusion Protein Preserves Myocardial Function after Transient Ischemia in Mice.</title>
            <link>http://www.medworm.com/index.php?rid=5579485&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22223428%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: These results indicate that administration of SDF1-GPVI may be a promising strategy to treat MI to promote myocardial repair and to preserve cardiac function.
    PMID: 22223428 [PubMed - as supplied by publisher] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5579485</comments>
            <pubDate>Thu, 05 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5579485</guid>        </item>
        <item>
            <title>Hyponatremia, Hypernatremia and Mortality in Patients with Chronic Kidney Disease with and without Congestive Heart Failure.</title>
            <link>http://www.medworm.com/index.php?rid=5579484&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22223429%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: Both lower and higher serum sodium levels are independently associated with higher mortality in patients with non-dialysis dependent CKD, irrespective of the presence of absence of congestive heart failure.
    PMID: 22223429 [PubMed - as supplied by publisher] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5579484</comments>
            <pubDate>Thu, 05 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5579484</guid>        </item>
        <item>
            <title>Myocardial Ischemic Events in Patients with Atrial Fibrillation Treated with Dabigatran or Warfarin in the RE-LY Trial.</title>
            <link>http://www.medworm.com/index.php?rid=5563538&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22215856%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: There was a non-significant increase in MI with dabigatran compared to warfarin, but other myocardial ischemic events were not increased. Treatment effects of dabigatran are consistent in patients at higher and lower risk of myocardial ischemic events. CLINICAL TRIAL REGISTRATION INFORMATION: ClinicalTrials.gov; NCT 00262600.
    PMID: 22215856 [PubMed - as supplied by publisher] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5563538</comments>
            <pubDate>Tue, 03 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5563538</guid>        </item>
        <item>
            <title>Downregulation of TMEM16A Calcium-Activated Chloride Channel Contributes to Cerebrovascular Remodeling during Hypertension through Promoting Basilar Smooth Muscle Cell Proliferation.</title>
            <link>http://www.medworm.com/index.php?rid=5563537&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22215857%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: TMEM16A CaCC is a negative regulator of cell proliferation. Downregulation of CaCC may play an important role in hypertension-induced cerebrovascular remodeling, suggesting modification of the activity of CaCC may be a novel therapeutic strategy for hypertension-associated cardiovascular diseases, such as stroke.
    PMID: 22215857 [PubMed - as supplied by publisher] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5563537</comments>
            <pubDate>Tue, 03 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5563537</guid>        </item>
        <item>
            <title>The Risk of Sudden Death in Wolff-Parkinson-White Syndrome: How High is the Risk?</title>
            <link>http://www.medworm.com/index.php?rid=5563536&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22215858%26dopt%3DAbstract</link>
            <description>Authors: Obeyesekere M, Gula LJ, Skanes AC, Leong-Sit P, Klein GJ
    Abstract
    In 1930, Dr. Louis Wolff, Sir John Parkinson and Paul Dudley White described a case series of 11 patients with a syndrome that now bears their name(1). The first patient with a short PR interval, ventricular pre-excitation and supraventricular tachycardia (SVT) was described by Cohn and Fraser in 1913(1). Wood et al postulated the accessory pathway (AP) as its anatomical substrate in 1942 and a large population series reported the prevalence of pre-excitation to be 0.15% in 1962(2). Reports in 1971 and 1979 described sudden cardiac death (SCD) in WPW patients related to atrial fibrillation (AF) conducting rapidly over the AP with a short refractory period that deteriorated into ventricular fibrillation (VF)(...</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5563536</comments>
            <pubDate>Tue, 03 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5563536</guid>        </item>
        <item>
            <title>Risk of Malignant Arrhythmias in Initially Symptomatic Patients with WPW Syndrome: Results of a Prospective Long-Term Electrophysiological Follow-Up Study.</title>
            <link>http://www.medworm.com/index.php?rid=5563535&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22215859%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: Symptomatic patients with WPW syndrome generally have a good outcome and predictors of malignant arrhythmias are similar to those reported for asymptomatic patients with ventricular preexcitation.
    PMID: 22215859 [PubMed - as supplied by publisher] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5563535</comments>
            <pubDate>Tue, 03 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5563535</guid>        </item>
        <item>
            <title>Editorial board.</title>
            <link>http://www.medworm.com/index.php?rid=5563534&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22215889%26dopt%3DAbstract</link>
            <description>Authors: 
    PMID: 22215889 [PubMed - in process] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5563534</comments>
            <pubDate>Tue, 03 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5563534</guid>        </item>
        <item>
            <title>Newer oral anticoagulants should be used as first-line agents to prevent thromboembolism in patients with atrial fibrillation and risk factors for stroke or thromboembolism.</title>
            <link>http://www.medworm.com/index.php?rid=5563533&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22215890%26dopt%3DAbstract</link>
            <description>Authors: Granger CB, Armaganijan LV
    PMID: 22215890 [PubMed - in process] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5563533</comments>
            <pubDate>Tue, 03 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5563533</guid>        </item>
        <item>
            <title>New oral anticoagulants should not be used as first-line agents to prevent thromboembolism in patients with atrial fibrillation.</title>
            <link>http://www.medworm.com/index.php?rid=5563532&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22215891%26dopt%3DAbstract</link>
            <description>Authors: Ansell J
    PMID: 22215891 [PubMed - in process] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5563532</comments>
            <pubDate>Tue, 03 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5563532</guid>        </item>
        <item>
            <title>Behavioral strategies for cardiovascular risk reduction in diverse and underserved racial/ethnic groups.</title>
            <link>http://www.medworm.com/index.php?rid=5563531&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22215892%26dopt%3DAbstract</link>
            <description>Authors: Stuart-Shor EM, Berra KA, Kamau MW, Kumanyika SK
    PMID: 22215892 [PubMed - in process] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5563531</comments>
            <pubDate>Tue, 03 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5563531</guid>        </item>
        <item>
            <title>Echinococcosis of the heart and ascending aorta.</title>
            <link>http://www.medworm.com/index.php?rid=5563530&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22215893%26dopt%3DAbstract</link>
            <description>Authors: Gerber BL, Pasquet A, El Khoury G, Verhelst R, Vanoverschelde JL, Watremez C, Vancraeynest D
    PMID: 22215893 [PubMed - in process] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5563530</comments>
            <pubDate>Tue, 03 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5563530</guid>        </item>
        <item>
            <title>Executive Summary: Heart Disease and Stroke Statistics--2012 Update: A Report From the American Heart Association.</title>
            <link>http://www.medworm.com/index.php?rid=5563529&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22215894%26dopt%3DAbstract</link>
            <description>Authors:  , Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford ES, Fox CS, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Makuc DM, Marcus GM, Marelli A, Matchar DB, Moy CS, Mozaffarian D, Mussolino ME, Nichol G, Paynter NP, Soliman EZ, Sorlie PD, Sotoodehnia N, Turan TN, Virani SS, Wong ND, Woo D, Turner MB, , 
    PMID: 22215894 [PubMed - as supplied by publisher] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5563529</comments>
            <pubDate>Tue, 03 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5563529</guid>        </item>
        <item>
            <title>When side matters: contrast echocardiography with injection from the left antecubital vein to detect a persistent left superior vena cava draining to the left atrium in a patient with cerebral stroke.</title>
            <link>http://www.medworm.com/index.php?rid=5563528&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22215895%26dopt%3DAbstract</link>
            <description>Authors: Butera G, Salvia J, Carminati M
    PMID: 22215895 [PubMed - in process] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5563528</comments>
            <pubDate>Tue, 03 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5563528</guid>        </item>
        <item>
            <title>Circulation Editors' Picks: Most Read Articles in Aortic Disease.</title>
            <link>http://www.medworm.com/index.php?rid=5563527&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22215896%26dopt%3DAbstract</link>
            <description>Authors:  
    Abstract
    The following articles are being highlighted as part of Circulation's Topic Review series. This series will summarize the most important manuscripts, as selected by the editors, published in Circulation and the Circulation subspecialty journals. The studies included in this article represent the most read manuscripts published on the topic of aortic disease in 2010 and 2011.
    PMID: 22215896 [PubMed - as supplied by publisher] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5563527</comments>
            <pubDate>Tue, 03 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5563527</guid>        </item>
        <item>
            <title>Letter by Van Laecke and Vanholder Regarding Article, &quot;Risk of Recurrent Cardiac Events After Onset of Menopause in Women With Congenital Long-QT Syndrome Types 1 and 2&quot;.</title>
            <link>http://www.medworm.com/index.php?rid=5563526&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22215897%26dopt%3DAbstract</link>
            <description>Letter by Van Laecke and Vanholder Regarding Article, &quot;Risk of Recurrent Cardiac Events After Onset of Menopause in Women With Congenital Long-QT Syndrome Types 1 and 2&quot;.
    Circulation. 2012 Jan 3;125(1):e236
    Authors: Van Laecke S, Vanholder R
    PMID: 22215897 [PubMed - in process] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5563526</comments>
            <pubDate>Tue, 03 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5563526</guid>        </item>
        <item>
            <title>Letter to the editor by kohrmann and schellinger regarding article, &quot;current status of endovascular stroke treatment&quot;.</title>
            <link>http://www.medworm.com/index.php?rid=5563525&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22215898%26dopt%3DAbstract</link>
            <description>Letter to the editor by kohrmann and schellinger regarding article, &quot;current status of endovascular stroke treatment&quot;.
    Circulation. 2012 Jan 3;125(1):e237
    Authors: Köhrmann M, Schellinger PD
    PMID: 22215898 [PubMed - in process] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5563525</comments>
            <pubDate>Tue, 03 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5563525</guid>        </item>
        <item>
            <title>Letter by Ravensbergen et al Regarding Article, &quot;Long-Term Recording of Cardiac Arrhythmias With an Implantable Cardiac Monitor in Patients With Reduced Ejection Fraction After Acute Myocardial Infarction: The Cardiac Arrhythmias and Risk Stratification After Acute Myocardial Infarction (CARISMA) Study&quot;.</title>
            <link>http://www.medworm.com/index.php?rid=5563524&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22215899%26dopt%3DAbstract</link>
            <description>Letter by Ravensbergen et al Regarding Article, &quot;Long-Term Recording of Cardiac Arrhythmias With an Implantable Cardiac Monitor in Patients With Reduced Ejection Fraction After Acute Myocardial Infarction: The Cardiac Arrhythmias and Risk Stratification After Acute Myocardial Infarction (CARISMA) Study&quot;.
    Circulation. 2012 Jan 3;125(1):e239
    Authors: Ravensbergen NJ, Verhagen HJ, De Melis M
    PMID: 22215899 [PubMed - in process] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5563524</comments>
            <pubDate>Tue, 03 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5563524</guid>        </item>
        <item>
            <title>Sirolimus as Primary Immunosuppression Attenuates Allograft Vasculopathy with Improved Late Survival and Decreased Cardiac Events Following Cardiac Transplantation.</title>
            <link>http://www.medworm.com/index.php?rid=5563539&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22207715%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: Substituting CNI with SRL as primary immunosuppressant attenuates long term CAV progression and may improve long-term allograft survival due to favorable coronary remodeling. Because of the lack of randomization, and retrospective nature of our analysis, the differences in outcome should be interpreted cautiously and prospective clinical trials would be required.
    PMID: 22207715 [PubMed - as supplied by publisher] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5563539</comments>
            <pubDate>Thu, 29 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5563539</guid>        </item>
        <item>
            <title>Identification of a Monocyte-Predisposed Hierarchy of Hematopoietic Progenitor Cells in the Adventitia of Postnatal Murine Aorta.</title>
            <link>http://www.medworm.com/index.php?rid=5551748&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22203692%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: The postnatal murine aorta contains rare multipotent HPCs/HSCs and is selectively enriched with Sca-1(+) monocyte/macrophage precursors. These populations may represent novel, local vascular sources of inflammatory cells.
    PMID: 22203692 [PubMed - as supplied by publisher] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5551748</comments>
            <pubDate>Tue, 27 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5551748</guid>        </item>
        <item>
            <title>Aortic Tissue as a Niche for Hematopoiesis.</title>
            <link>http://www.medworm.com/index.php?rid=5551747&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22203693%26dopt%3DAbstract</link>
            <description>Authors: Yoder MC
    Abstract
    The stem cell theory of hematopoiesis predicts that all mature blood cell lineages circulating in the bloodstream or resident in tissues, arise via a hierarchy of hematopoietic progenitor cell (HPC) intermediates that are ultimately derived from hematopoietic stem cells (HSC). In the adult human subject, bone marrow resident HSC and HPC generate billions of circulating blood cells daily, ranging from the short-lived neutrophils and platelets to long-lived B and T lymphocytes and monocyte-macrophages. Recent interest in the roles of macrophages as modulators of angiogenesis(1) and as participants in atheroma formation(2) highlight the need to better understand the mechanisms of recruitment and retention of macrophages and their progenitor precursors within...</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5551747</comments>
            <pubDate>Tue, 27 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5551747</guid>        </item>
        <item>
            <title>Very Late Stent Thrombosis and Late Target Lesion Revascularization after Sirolimus-Eluting Stent Implantation: Five-year Outcome of the j-Cypher Registry.</title>
            <link>http://www.medworm.com/index.php?rid=5551746&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22203694%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: Late adverse events such as very late ST and late TLR are the continuous hazard lasting at least up to 5 years after implantation of the first generation drug-eluting stents (SES), which should be the targets in developing improved coronary stents.
    PMID: 22203694 [PubMed - as supplied by publisher] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5551746</comments>
            <pubDate>Tue, 27 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5551746</guid>        </item>
        <item>
            <title>Very Late Stent Thrombosis and Late Target Lesion Revascularization: No End in Sight.</title>
            <link>http://www.medworm.com/index.php?rid=5551745&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22203695%26dopt%3DAbstract</link>
            <description>Authors: Faxon DP
    Abstract
    Randomized trials and registries have clearly demonstrated that drug-eluting stents (DES) are effective in reducing restenosis(1,2). Following their introduction and an initial period of unbridled enthusiasm, it was recognized that there was a significant increase in very late stent thrombosis (VLST) when compared to bare metal stents (BMS) and this late complication has been the subject of continued concern and intensive investigation. Very late ST is fortunately infrequent but it is associated with very high rates of death and myocardial infarction. Understanding the frequency, duration and potential mechanisms of VSLT have been hampered by the lack of large studies where low frequency events can be more accurately determined and evaluated. Randomized t...</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5551745</comments>
            <pubDate>Tue, 27 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5551745</guid>        </item>
        <item>
            <title>Type II Diabetes Mellitus is Associated with Faster Degeneration of Bioprosthetic Valve: Results from a Propensity Score-Matched Italian Multicenter Study.</title>
            <link>http://www.medworm.com/index.php?rid=5551744&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22203696%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: Patients with type II DM undergoing bioprosthetic valve implantation are at high risk of early and long-term mortality as well as of SVD.
    PMID: 22203696 [PubMed - as supplied by publisher] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5551744</comments>
            <pubDate>Tue, 27 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5551744</guid>        </item>
        <item>
            <title>&quot;Circulation&quot;[ta]; +101 new citations</title>
            <link>http://www.medworm.com/index.php?rid=5537073&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fsites%2Fentrez%3Fcmd%3DSearch%26db%3Dpubmed%26term%3D%28%2520%28%2522Circulation%2522%255Bta%255D%29%2520AND%2520%25222011%252F11%252F19%252015.54%2522%255BEDAT%255D%253A%25222011%252F12%252F24%252016.24%2522%255BEDAT%255D%29</link>
            <description>101 new pubmed citations were retrieved for your search.
Click on the search hyperlink below to display the complete search results:

&quot;Circulation&quot;[ta]
These pubmed results were generated on 2011/12/24PubMed, a service of the National Library of Medicine, includes over 15 million 
citations for biomedical articles back to the 1950's.
These citations are from MEDLINE and additional life science journals. 
PubMed includes links to many sites providing full text articles and other related resources. (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5537073</comments>
            <pubDate>Sat, 24 Dec 2011 21:24:02 +0100</pubDate>
            <guid isPermaLink="false">5537073</guid>        </item>
        <item>
            <title>Status of Cardiovascular Health in US Adults: Prevalence Estimates from the National Health and Nutrition Examination Surveys (NHANES) 2003-2008.</title>
            <link>http://www.medworm.com/index.php?rid=5424689&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22095826%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: -These prevalence estimates of CV health represent a starting point from which effectiveness of efforts to promote CV health and prevent CV disease can be monitored and compared in U.S. adult populations.
    PMID: 22095826 [PubMed - as supplied by publisher] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5424689</comments>
            <pubDate>Thu, 17 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5424689</guid>        </item>
        <item>
            <title>Niacin Inhibits Vascular Inflammation via the Induction of Heme Oxygenase-1.</title>
            <link>http://www.medworm.com/index.php?rid=5424688&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22095827%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: -Niacin activates HO-1 in vivo and in vitro. Induction of HO-1 may be partly responsible for the vascular protective properties of niacin.
    PMID: 22095827 [PubMed - as supplied by publisher] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5424688</comments>
            <pubDate>Thu, 17 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5424688</guid>        </item>
        <item>
            <title>Physician Procedure Volume and Complications of Cardioverter-Defibrillator Implantation.</title>
            <link>http://www.medworm.com/index.php?rid=5424687&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22095828%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: -Physicians who implant more ICDs have lower rates of procedural complications and in-hospital mortality, independent of hospital procedure volume, physician specialty, and ICD type.
    PMID: 22095828 [PubMed - as supplied by publisher] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5424687</comments>
            <pubDate>Thu, 17 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5424687</guid>        </item>
        <item>
            <title>Multipotent Vasculogenic Pericytes from Human Pluripotent Stem Cells Promote Recovery of Murine Ischemic Limb.</title>
            <link>http://www.medworm.com/index.php?rid=5424686&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22095829%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: -Derivation of vasculogenic and multipotent pericytes from hPSC can be used for the development of vasculogenic models using multiple vasculogenic cell types for basic research and drug screening and can contribute to angiogenic regenerative medicine.
    PMID: 22095829 [PubMed - as supplied by publisher] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5424686</comments>
            <pubDate>Thu, 17 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5424686</guid>        </item>
        <item>
            <title>From Pluri- to Multipotency via Vascular Pericytes; Are Mural Cells Guardians of Stemness?</title>
            <link>http://www.medworm.com/index.php?rid=5424685&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22095830%26dopt%3DAbstract</link>
            <description>Authors: Péault B
    Abstract
    In this issue of Circulation, Dar and collaborators report the healing of ischemic limbs in athymic mice bymultipotent progenitors derived from human embryonic stem cells orreprogrammed adult cells. So far, nothing really original; the excitement comes from the demonstration that these ES- and iPS-cell derived regenerative units exhibit the features of vascular pericytes(1). These observations are timely and remarkable inasmuch as the blood vessel, far away from a mere conduit, has lately gained nobility in the eyes of stem cell biologists for its recognized contribution to diverse cell lineages. On the one hand, it is now well accepted that, from fish to humans, specialized &quot;blood-forming&quot; endothelial cells in thedorsal aortaand, most certainly, other o...</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5424685</comments>
            <pubDate>Thu, 17 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5424685</guid>        </item>
        <item>
            <title>Assessment of Valvular Calcification and Inflammation by Positron Emission Tomography in Patients with Aortic Stenosis.</title>
            <link>http://www.medworm.com/index.php?rid=5424695&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22090163%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: -Positron emission tomography is a novel, feasible and repeatable approach to thee valuation of valvular calcification and inflammation in patients with aortic stenosis. The frequency and magnitude of increased tracer activity correlates with disease severity, and is strongest for 18F-NaF. Clinical Trial Registration Information-ClinicalTrials.gov; Reference Number: NCT01358513.
    PMID: 22090163 [PubMed - as supplied by publisher] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5424695</comments>
            <pubDate>Wed, 16 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5424695</guid>        </item>
        <item>
            <title>Look More Closely at the Valve: Imaging Calcific Aortic Valve Disease.</title>
            <link>http://www.medworm.com/index.php?rid=5424694&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22090164%26dopt%3DAbstract</link>
            <description>Authors: Aikawa E, Otto CM
    Abstract
    Outcome measures in patients with aortic stenosisClinical trials of medical therapy to prevent progression in calcific aortic valve disease (CAVD) are hampered by the lack of sensitive measures of disease activity in the valve leaflets. Although the long-term goal of therapy is to prevent adverse cardiovascular outcomes, including mortality and aortic valve replacement, these endpoints have several limitations. First, the &quot;hard&quot; endpoint of mortality is frequently impacted by comorbid conditions. Patients with CAVD typically are elderly with a high prevalence of coronary and noncardiac disease so that isolating the effect of valve obstruction on survival is problematic. Second, the endpoint of valve replacement for symptom onset reflects consider...</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5424694</comments>
            <pubDate>Wed, 16 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5424694</guid>        </item>
        <item>
            <title>Loss-of-Function Sodium Channel Mutations in Infancy: A Pattern Unfolds.</title>
            <link>http://www.medworm.com/index.php?rid=5424693&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22090165%26dopt%3DAbstract</link>
            <description>Authors: Chockalingam P, Wilde AA
    Abstract
    The role of channelopathies in the pathogenesis of sudden cardiac death (SCD) in patients with structurally normal hearts is a rapidly evolving story.(1) Many ion channels are involved, including loss-of-function sodium channelopathies of which the phenotypic spectrum ranges from lethal arrhythmias to asymptomatic carriers and includes Brugada Syndrome (BrS), cardiac conduction disease, sick sinus syndrome, atrial fibrillation and dilated cardiomyopathy. BrS, characterized by right precordial ST elevation on the electrocardiogram, is frequently associated with conduction delay, potentially lethal arrhythmias, and a positive family history of sudden premature death. BrS is estimated to be responsible for approximately 4% of all sudden death...</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5424693</comments>
            <pubDate>Wed, 16 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5424693</guid>        </item>
        <item>
            <title>Brugada-Like Syndrome in Infancy Presenting with Rapid Ventricular Tachycardia and Intraventricular Conduction Delay.</title>
            <link>http://www.medworm.com/index.php?rid=5424692&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22090166%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: -Infants having rapid ventricular tachycardia and conduction abnormalities in the absence of structural or metabolic abnormalities are likely to have disease-causing mutations in cardiac depolarizing channels.
    PMID: 22090166 [PubMed - as supplied by publisher] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5424692</comments>
            <pubDate>Wed, 16 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5424692</guid>        </item>
        <item>
            <title>Colchicine Reduces Postoperative Atrial Fibrillation: Results of the Colchicine for the Prevention of the Postpericardiotomy Syndrome (COPPS) Atrial Fibrillation Substudy.</title>
            <link>http://www.medworm.com/index.php?rid=5424691&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22090167%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: . Unique identifier: NCT00128427.
    PMID: 22090167 [PubMed - as supplied by publisher] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5424691</comments>
            <pubDate>Wed, 16 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5424691</guid>        </item>
        <item>
            <title>Supervised Exercise Versus Primary Stenting for Claudication Resulting From Aortoiliac Peripheral Artery Disease: Six-Month Outcomes From the Claudication: Exercise Versus Endoluminal Revascularization (CLEVER) Study.</title>
            <link>http://www.medworm.com/index.php?rid=5424690&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22090168%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: . Unique identifier: NCT00132743.
    PMID: 22090168 [PubMed - as supplied by publisher] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5424690</comments>
            <pubDate>Wed, 16 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5424690</guid>        </item>
        <item>
            <title>QTc Behavior During Exercise and Genetic Testing for the Long-QT Syndrome.</title>
            <link>http://www.medworm.com/index.php?rid=5424712&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22083145%26dopt%3DAbstract</link>
            <description>Authors: Schwartz PJ, Crotti L
    PMID: 22083145 [PubMed - in process] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5424712</comments>
            <pubDate>Tue, 15 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5424712</guid>        </item>
        <item>
            <title>Definition of early repolarization: a tug of war.</title>
            <link>http://www.medworm.com/index.php?rid=5424711&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22083146%26dopt%3DAbstract</link>
            <description>Authors: Derval N, Shah A, Jaïs P
    PMID: 22083146 [PubMed - in process] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5424711</comments>
            <pubDate>Tue, 15 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5424711</guid>        </item>
        <item>
            <title>Iron overload cardiomyopathy in clinical practice.</title>
            <link>http://www.medworm.com/index.php?rid=5424710&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22083147%26dopt%3DAbstract</link>
            <description>Authors: Kremastinos DT, Farmakis D
    PMID: 22083147 [PubMed - in process] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5424710</comments>
            <pubDate>Tue, 15 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5424710</guid>        </item>
        <item>
            <title>Atrial fibrillation pathophysiology: implications for management.</title>
            <link>http://www.medworm.com/index.php?rid=5424709&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22083148%26dopt%3DAbstract</link>
            <description>This article reviews the basic pathophysiology of AF over a broad range of levels, touching on the tissue mechanisms that maintain the arrhythmia, the relationship between clinical presentation and basic mechanisms, ion channel and transporter abnormalities that lead to ectopic impulse formation, basic models and tissue determinants of reentry, ion channel determinants of reentry, the nature and roles of electric and structural remodeling, autonomic neural components, anatomic factors, interactions between atrial and ventricular functional consequences of AF, and the basic determinants of atrial thromboembolism. We then review the potential implications of the basic pathophysiology of the arrhythmia for its management. We first discuss consequences for improved rhythm control pharmacothera...</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5424709</comments>
            <pubDate>Tue, 15 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5424709</guid>        </item>
        <item>
            <title>Giant intramural left ventricular rhabdomyoma in a newborn.</title>
            <link>http://www.medworm.com/index.php?rid=5424708&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22083149%26dopt%3DAbstract</link>
            <description>Authors: Padalino MA, Vida VL, Bhattarai A, Reffo E, Milanesi O, Thiene G, Stellin G, Basso C
    PMID: 22083149 [PubMed - in process] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5424708</comments>
            <pubDate>Tue, 15 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5424708</guid>        </item>
        <item>
            <title>An inverted location of the bicuspid valve disease: a variant of a variant.</title>
            <link>http://www.medworm.com/index.php?rid=5424707&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22083150%26dopt%3DAbstract</link>
            <description>Authors: Magnoni M, Turri C, Roghi A, Merlanti B, Maseri A
    PMID: 22083150 [PubMed - in process] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5424707</comments>
            <pubDate>Tue, 15 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5424707</guid>        </item>
        <item>
            <title>Advances in the epidemiology of heart failure and left ventricular remodeling.</title>
            <link>http://www.medworm.com/index.php?rid=5424706&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22083151%26dopt%3DAbstract</link>
            <description>Authors: Cheng S, Vasan RS
    PMID: 22083151 [PubMed - in process] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5424706</comments>
            <pubDate>Tue, 15 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5424706</guid>        </item>
        <item>
            <title>Circulation Editors' Picks: Most Read Articles in Epidemiology and Prevention, Part II.</title>
            <link>http://www.medworm.com/index.php?rid=5424705&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22083152%26dopt%3DAbstract</link>
            <description>Authors:  
    Abstract
    The following articles are being highlighted as part of Circulation's Topic Review series. This series will summarize the most important manuscripts, as selected by the editors, published in Circulation and the Circulation subspecialty journals. The studies included in this article represent the most read manuscripts published on the topic of epidemiology and prevention in 2009 and 2010.
    PMID: 22083152 [PubMed - as supplied by publisher] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5424705</comments>
            <pubDate>Tue, 15 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5424705</guid>        </item>
        <item>
            <title>Letter by falk regarding article, &quot;an unusual heart failure: cardiac amyloidosis due to light chain myeloma&quot;.</title>
            <link>http://www.medworm.com/index.php?rid=5424704&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22083153%26dopt%3DAbstract</link>
            <description>Letter by falk regarding article, &quot;an unusual heart failure: cardiac amyloidosis due to light chain myeloma&quot;.
    Circulation. 2011 Nov 15;124(20):e534
    Authors: Falk RH
    PMID: 22083153 [PubMed - in process] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5424704</comments>
            <pubDate>Tue, 15 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5424704</guid>        </item>
        <item>
            <title>Letter by anyfanti et Al regarding article, &quot;effect of renal sympathetic denervation on glucose metabolism in patients with resistant hypertension: a pilot study&quot;.</title>
            <link>http://www.medworm.com/index.php?rid=5424703&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22083154%26dopt%3DAbstract</link>
            <description>Letter by anyfanti et Al regarding article, &quot;effect of renal sympathetic denervation on glucose metabolism in patients with resistant hypertension: a pilot study&quot;.
    Circulation. 2011 Nov 15;124(20):e536
    Authors: Anyfanti P, Gkaliagkousi E, Douma S
    PMID: 22083154 [PubMed - in process] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5424703</comments>
            <pubDate>Tue, 15 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5424703</guid>        </item>
        <item>
            <title>Protection Against Myocardial Infarction and No-Reflow Through Preservation of Vascular Integrity by Angiopoietin-Like 4.</title>
            <link>http://www.medworm.com/index.php?rid=5424702&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22086875%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: -These data showed that ANGPTL4 might constitute a relevant target for therapeutic vasculoprotection aimed at counteracting the effects of VEGF, thus being crucial for preventing no-reflow and conferring secondary cardioprotection during AMI.
    PMID: 22086875 [PubMed - as supplied by publisher] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5424702</comments>
            <pubDate>Tue, 15 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5424702</guid>        </item>
        <item>
            <title>GSK-3α Limits Ischemic Injury, Cardiac Rupture, Post- Myocardial Infarction Remodeling and Death.</title>
            <link>http://www.medworm.com/index.php?rid=5424701&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22086876%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: -GSK-3α confers resistance to ischemic injury at least in part via limiting apoptosis. Loss of GSK-3α promotes ischemic injury, increases risk of cardiac rupture, accentuates post-MI remodeling and LV dysfunction, and increases the progression to heart failure. These findings are in striking contrast to multiple prior reports in which deletion or inhibition of GSK-3β is protective.
    PMID: 22086876 [PubMed - as supplied by publisher] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5424701</comments>
            <pubDate>Tue, 15 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5424701</guid>        </item>
        <item>
            <title>Hybrid Open Endovascular Technique for Aortic Thoracoabdominal Pathologies.</title>
            <link>http://www.medworm.com/index.php?rid=5424700&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22086877%26dopt%3DAbstract</link>
            <description>Conclusions-The repair of thoracoabdominal pathologies by means of hybrid procedures in patients who are poor surgical candidates is still associated with significant morbidity and mortality rates. Future studies may substantiate whether the technique is amenable to amelioration and improvement.
    PMID: 22086877 [PubMed - as supplied by publisher] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5424700</comments>
            <pubDate>Tue, 15 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5424700</guid>        </item>
        <item>
            <title>Safety and Efficacy of Allogeneic Cell Therapy in Infarcted Rats Transplanted with Mismatched Cardiosphere-Derived Cells.</title>
            <link>http://www.medworm.com/index.php?rid=5424699&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22086878%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: -Allogeneic CDC transplantation without immunosuppression is safe, promotes cardiac regeneration and improves heart function in a rat myocardial infarction model, mainly through stimulation of endogenous repair mechanisms. This indirect mechanism of action rationalizes the persistence of benefit despite the evanescence of transplanted cell survival. This work motivates the testing of allogeneic human CDCs as a potential off-the-shelf product for cellular cardiomyoplasty.
    PMID: 22086878 [PubMed - as supplied by publisher] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5424699</comments>
            <pubDate>Tue, 15 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5424699</guid>        </item>
        <item>
            <title>Treatment of Unexplained Syncope: A Multicenter, Randomized Trial of Cardiac Pacing Guided by Adenosine 5'-triphosphate Testing.</title>
            <link>http://www.medworm.com/index.php?rid=5424698&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22086879%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: -This study suggests that, in elderly patients with SUO and positive ATP tests, active dual-chamber pacing reduces syncope recurrence risk by 75% (95% CI 44% to 88%).Clinical Trial Registration Information-http://www.controlled-trials.com/ISRCTN00029383; Unique Identifier: ISRCTN00029383.
    PMID: 22086879 [PubMed - as supplied by publisher] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5424698</comments>
            <pubDate>Tue, 15 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5424698</guid>        </item>
        <item>
            <title>Comparison of the Durations of Mild Therapeutic Hypothermia on Outcome Following Cardiopulmonary Resuscitation in the Rat.</title>
            <link>http://www.medworm.com/index.php?rid=5424697&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22086880%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: -In a rat model of CPR, a shorter duration of mild hypothermia induced rapidly and early following ROSC improved post-resuscitation microcirculation, myocardial and cerebral functions and survival equally or better than prolonged duration of hypothermia following resuscitation.
    PMID: 22086880 [PubMed - as supplied by publisher] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5424697</comments>
            <pubDate>Tue, 15 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5424697</guid>        </item>
        <item>
            <title>Survival in Childhood Pulmonary Arterial Hypertension:Insights From the Registry to Evaluate Early and Long-term PAH Disease Management.</title>
            <link>http://www.medworm.com/index.php?rid=5424696&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22086881%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: -Utilizing the REVEAL Registry, we identified key predictors of survival in childhood PAH. Refining these prognostic parameters should help clinicians improve outcomes.Clinical Trial Registration Information-ClinicalTrials.gov; Identifier: NCT00370214.
    PMID: 22086881 [PubMed - as supplied by publisher] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5424696</comments>
            <pubDate>Tue, 15 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5424696</guid>        </item>
        <item>
            <title>Efficacy and Safety of Celivarone, With Amiodarone as Calibrator, in Patients With an Implantable Cardioverter-Defibrillator for Prevention of Implantable Cardioverter-Defibrillator Interventions or Death: The ALPHEE Study.</title>
            <link>http://www.medworm.com/index.php?rid=5424722&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22082672%26dopt%3DAbstract</link>
            <description>Authors: Kowey PR, Crijns HJ, Aliot EM, Capucci A, Kulakowski P, Radzik D, Roy D, Connolly SJ, Hohnloser SH, 
    Abstract
    BACKGROUND: . Unique identifier: NCT00993382.
    PMID: 22082672 [PubMed - as supplied by publisher] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5424722</comments>
            <pubDate>Mon, 14 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5424722</guid>        </item>
        <item>
            <title>Atrial Fibrillation Catheter Ablation Versus Surgical Ablation Treatment (FAST): A 2-Center Randomized Clinical Trial.</title>
            <link>http://www.medworm.com/index.php?rid=5424721&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22082673%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: . Unique identifier: NCT00662701.
    PMID: 22082673 [PubMed - as supplied by publisher] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5424721</comments>
            <pubDate>Mon, 14 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5424721</guid>        </item>
        <item>
            <title>Pak1 as a Novel Therapeutic Target for Antihypertrophic Treatment in the Heart.</title>
            <link>http://www.medworm.com/index.php?rid=5424720&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22082674%26dopt%3DAbstract</link>
            <description>Conclusions-These results, for the first time, establish Pak1 as a novel antihypertrophic regulator and suggest that it may be a potential therapeutic target for the treatment of cardiac hypertrophy and heart failure.
    PMID: 22082674 [PubMed - as supplied by publisher] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5424720</comments>
            <pubDate>Mon, 14 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5424720</guid>        </item>
        <item>
            <title>A Critical Role for the Protein Apoptosis Repressor With Caspase Recruitment Domain in Hypoxia-Induced Pulmonary Hypertension.</title>
            <link>http://www.medworm.com/index.php?rid=5424719&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22082675%26dopt%3DAbstract</link>
            <description>Conclusions-These data show that ARC, previously unlinked to pulmonary hypertension, is a critical determinant of vascular remodeling in this syndrome.
    PMID: 22082675 [PubMed - as supplied by publisher] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5424719</comments>
            <pubDate>Mon, 14 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5424719</guid>        </item>
        <item>
            <title>Referral, Enrollment, and Delivery of Cardiac Rehabilitation/Secondary Prevention Programs at Clinical Centers and Beyond: A Presidential Advisory From the American Heart Association.</title>
            <link>http://www.medworm.com/index.php?rid=5424718&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22082676%26dopt%3DAbstract</link>
            <description>Authors: Balady GJ, Ades PA, Bittner VA, Franklin BA, Gordon NF, Thomas RJ, Tomaselli GF, Yancy CW
    PMID: 22082676 [PubMed - as supplied by publisher] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5424718</comments>
            <pubDate>Mon, 14 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5424718</guid>        </item>
        <item>
            <title>Heparin Elevates Circulating Soluble fms-Like Tyrosine Kinase-1 Immunoreactivity in Pregnant Women Receiving Anticoagulation Therapy.</title>
            <link>http://www.medworm.com/index.php?rid=5424717&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22082677%26dopt%3DAbstract</link>
            <description>Conclusions-Heparin likely increases the maternal sFlt-1 through shedding of the extracellular domain of Flt-1 receptor. Our results imply that upregulation of circulating sFlt-1 immunoreactivity in pregnancy is not always associated with adverse outcomes, and that heparin's protective effects, if any, cannot be explained by promotion of angiogenesis.
    PMID: 22082677 [PubMed - as supplied by publisher] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5424717</comments>
            <pubDate>Mon, 14 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5424717</guid>        </item>
        <item>
            <title>Pathogenic Cycle Between the Endogenous Nitric Oxide Synthase Inhibitor Asymmetrical Dimethylarginine and the Leukocyte-Derived Hemoprotein Myeloperoxidase.</title>
            <link>http://www.medworm.com/index.php?rid=5424716&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22082678%26dopt%3DAbstract</link>
            <description>Conclusions-ADMA profoundly impairs nitric oxide synthesis of PMNs, resulting in increased PMN adhesion to endothelial cells, superoxide generation, and release of MPO. In addition, MPO impairs DDAH1 activity. Our data reveal an ADMA-induced cycle of PMN activation, enhanced MPO release, and subsequent impairment of DDAH1 activity. These findings not only highlight so far unrecognized cytokine-like properties of ADMA but also identify MPO as a regulatory switch for ADMA bioavailability under inflammatory conditions.
    PMID: 22082678 [PubMed - as supplied by publisher] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5424716</comments>
            <pubDate>Mon, 14 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5424716</guid>        </item>
        <item>
            <title>Absence of SOCS3 in the Cardiomyocyte Increases Mortality in a gp130-Dependent Manner Accompanied by Contractile Dysfunction and Ventricular Arrhythmias.</title>
            <link>http://www.medworm.com/index.php?rid=5424715&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22082679%26dopt%3DAbstract</link>
            <description>Conclusions-Our results demonstrate an important role of SOCS3 regulation on cardiac gp130 signaling in the pathogenesis of contractile dysfunction and ventricular arrhythmias.
    PMID: 22082679 [PubMed - as supplied by publisher] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5424715</comments>
            <pubDate>Mon, 14 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5424715</guid>        </item>
        <item>
            <title>A Key Role for Matrix Metalloproteinases and Neutral Sphingomyelinase-2 in Transplant Vasculopathy Triggered by Anti-HLA Antibody.</title>
            <link>http://www.medworm.com/index.php?rid=5424714&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22082680%26dopt%3DAbstract</link>
            <description>Conclusions-These data highlight a crucial role for MMP2 and neutral sphingomyelinase-2 in vasculopathy triggered by a humoral immune response and open new perspectives for preventing transplant vasculopathy with the use of MMP and neutral sphingomyelinase inhibitors, in addition to conventional immunosuppression.
    PMID: 22082680 [PubMed - as supplied by publisher] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5424714</comments>
            <pubDate>Mon, 14 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5424714</guid>        </item>
        <item>
            <title>Predictive Value of the High-Sensitivity Troponin T Assay and the Simplified Pulmonary Embolism Severity Index in Hemodynamically Stable Patients With Acute Pulmonary Embolism: A Prospective Validation Study.</title>
            <link>http://www.medworm.com/index.php?rid=5424713&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22082681%26dopt%3DAbstract</link>
            <description>Conclusions-The hsTnT assay and the sPESI improve risk stratification of acute PE. Combination of both modalities may yield additive prognostic information and particularly identify possible candidates for out-of-hospital treatment.
    PMID: 22082681 [PubMed - as supplied by publisher] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5424713</comments>
            <pubDate>Mon, 14 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5424713</guid>        </item>
        <item>
            <title>Sleep disturbances: time to join the top 10 potentially modifiable cardiovascular risk factors?</title>
            <link>http://www.medworm.com/index.php?rid=5424733&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22064955%26dopt%3DAbstract</link>
            <description>Authors: Redline S, Foody J
    PMID: 22064955 [PubMed - in process] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5424733</comments>
            <pubDate>Tue, 08 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5424733</guid>        </item>
        <item>
            <title>Diversity of myocardial interstitial proteolytic pathways: gene deletion reveals unexpected consequences.</title>
            <link>http://www.medworm.com/index.php?rid=5424732&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22064956%26dopt%3DAbstract</link>
            <description>Authors: Spinale FG
    PMID: 22064956 [PubMed - in process] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5424732</comments>
            <pubDate>Tue, 08 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5424732</guid>        </item>
        <item>
            <title>Catheter-based reperfusion treatment of pulmonary embolism.</title>
            <link>http://www.medworm.com/index.php?rid=5424731&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22064957%26dopt%3DAbstract</link>
            <description>Authors: Engelberger RP, Kucher N
    PMID: 22064957 [PubMed - in process] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5424731</comments>
            <pubDate>Tue, 08 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5424731</guid>        </item>
        <item>
            <title>Sex/Gender differences in cardiovascular disease prevention: what a difference a decade makes.</title>
            <link>http://www.medworm.com/index.php?rid=5424730&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22064958%26dopt%3DAbstract</link>
            <description>Authors: Mosca L, Barrett-Connor E, Kass Wenger N
    PMID: 22064958 [PubMed - in process] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5424730</comments>
            <pubDate>Tue, 08 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5424730</guid>        </item>
        <item>
            <title>Longest survivor of pulmonary atresia with ventricular septal defect: well-developed major aortopulmonary collateral arteries demonstrated by multidetector computed tomography.</title>
            <link>http://www.medworm.com/index.php?rid=5424729&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22064959%26dopt%3DAbstract</link>
            <description>Authors: Fukui D, Kai H, Takeuchi T, Gondo T, Oba T, Mawatari K, Tonai T, Matsuo Y, Ueda S, Niiyama H, Ueno T, Imaizumi T
    PMID: 22064959 [PubMed - in process] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5424729</comments>
            <pubDate>Tue, 08 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5424729</guid>        </item>
        <item>
            <title>Constrictive pericarditis presenting as a large mediastinal mass causing functional tricuspid and pulmonary stenosis.</title>
            <link>http://www.medworm.com/index.php?rid=5424728&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22064960%26dopt%3DAbstract</link>
            <description>Authors: Ehl NF, Sündermann S, Geyer R, Thies S, Epp C, Weilenmann D, Falk V, Joerg L, Rickli H, Maeder MT
    PMID: 22064960 [PubMed - in process] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5424728</comments>
            <pubDate>Tue, 08 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5424728</guid>        </item>
        <item>
            <title>Changes in stroke epidemiology, prevention, and treatment.</title>
            <link>http://www.medworm.com/index.php?rid=5424727&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22064961%26dopt%3DAbstract</link>
            <description>Authors: Kinlay S
    PMID: 22064961 [PubMed - in process] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5424727</comments>
            <pubDate>Tue, 08 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5424727</guid>        </item>
        <item>
            <title>Circulation Editors' Picks: Most Read Articles in Epidemiology and Prevention, Part I.</title>
            <link>http://www.medworm.com/index.php?rid=5424726&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22064962%26dopt%3DAbstract</link>
            <description>Authors:  
    Abstract
    The following articles are being highlighted as part of Circulation's Topic Review series. This series will summarize the most important manuscripts, as selected by the editors, published in Circulation and the Circulation subspecialty journals. The studies included in this article represent the most read manuscripts published on the topic of epidemiology and prevention in 2009 and 2010.
    PMID: 22064962 [PubMed - as supplied by publisher] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5424726</comments>
            <pubDate>Tue, 08 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5424726</guid>        </item>
        <item>
            <title>Letter by vorpahl and kelm regarding article, &quot;stent thrombogenicity early in high-risk interventional settings is driven by stent design and deployment and protected by polymer-drug coatings&quot;.</title>
            <link>http://www.medworm.com/index.php?rid=5424725&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22064963%26dopt%3DAbstract</link>
            <description>Letter by vorpahl and kelm regarding article, &quot;stent thrombogenicity early in high-risk interventional settings is driven by stent design and deployment and protected by polymer-drug coatings&quot;.
    Circulation. 2011 Nov 8;124(19):e511
    Authors: Vorpahl M, Kelm M
    PMID: 22064963 [PubMed - in process] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5424725</comments>
            <pubDate>Tue, 08 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5424725</guid>        </item>
        <item>
            <title>2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.</title>
            <link>http://www.medworm.com/index.php?rid=5424724&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22068434%26dopt%3DAbstract</link>
            <description>Authors: Gersh BJ, Maron BJ, Bonow RO, Dearani JA, Fifer MA, Link MS, Naidu SS, Nishimura RA, Ommen SR, Rakowski H, Seidman CE, Towbin JA, Udelson JE, Yancy CW
    PMID: 22068434 [PubMed - as supplied by publisher] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5424724</comments>
            <pubDate>Tue, 08 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5424724</guid>        </item>
        <item>
            <title>2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: Executive Summary: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.</title>
            <link>http://www.medworm.com/index.php?rid=5424723&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22068435%26dopt%3DAbstract</link>
            <description>Authors: Gersh BJ, Maron BJ, Bonow RO, Dearani JA, Fifer MA, Link MS, Naidu SS, Nishimura RA, Ommen SR, Rakowski H, Seidman CE, Towbin JA, Udelson JE, Yancy CW
    PMID: 22068435 [PubMed - as supplied by publisher] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5424723</comments>
            <pubDate>Tue, 08 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5424723</guid>        </item>
        <item>
            <title>Prevalence and Significance of Alterations in Cardiac Structure and Function in Patients With Heart Failure and a Preserved Ejection Fraction.</title>
            <link>http://www.medworm.com/index.php?rid=5424744&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22064591%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: . Unique identifier: NCT00095238.
    PMID: 22064591 [PubMed - as supplied by publisher] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5424744</comments>
            <pubDate>Mon, 07 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5424744</guid>        </item>
        <item>
            <title>Benefit of Transferring ST-Segment-Elevation Myocardial Infarction Patients for Percutaneous Coronary Intervention Compared With Administration of Onsite Fibrinolytic Declines as Delays Increase.</title>
            <link>http://www.medworm.com/index.php?rid=5424743&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22064592%26dopt%3DAbstract</link>
            <description>Conclusion-PCI-related delays are extensive among patients transferred for X-PCI and are associated with poorer outcomes. No differential excess in mortality was seen with X-PCI compared with O-FT even with long PCI-related delays, but as XDB door-to-needle time times increase, the mortality advantage for X-PCI over O-FT declines.
    PMID: 22064592 [PubMed - as supplied by publisher] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5424743</comments>
            <pubDate>Mon, 07 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5424743</guid>        </item>
        <item>
            <title>Frailty Is Independently Associated With Short-Term Outcomes for Elderly Patients With Non-ST-Segment Elevation Myocardial Infarction.</title>
            <link>http://www.medworm.com/index.php?rid=5424742&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22064593%26dopt%3DAbstract</link>
            <description>Authors: Ekerstad N, Swahn E, Janzon M, Alfredsson J, Löfmark R, Lindenberger M, Carlsson P
    Abstract
    BACKGROUND: . Unique identifier: NCT01049997.
    PMID: 22064593 [PubMed - as supplied by publisher] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5424742</comments>
            <pubDate>Mon, 07 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5424742</guid>        </item>
        <item>
            <title>Mild Retinopathy Is a Risk Factor for Cardiovascular Mortality in Japanese With and Without Hypertension: The Ibaraki Prefectural Health Study.</title>
            <link>http://www.medworm.com/index.php?rid=5424741&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22064594%26dopt%3DAbstract</link>
            <description>Conclusions-Mild hypertensive retinopathy is a risk factor for cardiovascular mortality independently of cardiovascular risk factors among men and women with and without hypertension.
    PMID: 22064594 [PubMed - as supplied by publisher] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5424741</comments>
            <pubDate>Mon, 07 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5424741</guid>        </item>
        <item>
            <title>Statin Use in Outpatients With Obstructive Coronary Artery Disease.</title>
            <link>http://www.medworm.com/index.php?rid=5424740&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22064595%26dopt%3DAbstract</link>
            <description>Conclusions-Despite robust clinical trial evidence, a substantial number of patients with obstructive CAD remain untreated with statins. A small proportion were treated with nonstatin therapy, and 1 in 6 patients was simply untreated; half of the untreated patients had low-density lipoprotein cholesterol values &amp;lt;100 mg/dL. These findings illustrate important opportunities to improve lipid management in outpatients with obstructive CAD.
    PMID: 22064595 [PubMed - as supplied by publisher] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5424740</comments>
            <pubDate>Mon, 07 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5424740</guid>        </item>
        <item>
            <title>Identification of a Danger-Associated Peptide From Apolipoprotein B100 (ApoBDS-1) That Triggers Innate Proatherogenic Responses.</title>
            <link>http://www.medworm.com/index.php?rid=5424739&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22064596%26dopt%3DAbstract</link>
            <description>Conclusions-Our data show that ApoBDS-1 is a previously unrecognized peptide with robust proinflammatory activity, contributing to the disease-promoting effects of low-density lipoprotein in the pathogenesis of atherosclerosis.
    PMID: 22064596 [PubMed - as supplied by publisher] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5424739</comments>
            <pubDate>Mon, 07 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5424739</guid>        </item>
        <item>
            <title>m-Calpain Induction in Vascular Endothelial Cells on Human and Mouse Atheromas and Its Roles in VE-Cadherin Disorganization and Atherosclerosis.</title>
            <link>http://www.medworm.com/index.php?rid=5424738&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22064597%26dopt%3DAbstract</link>
            <description>Conclusions-Subtype-selective induction of m-calpain in aortic ECs during atherosclerotic progression is associated with proteolytic disorganization of VE-cadherin and proatherogenic hyperpermeability in cells. Thus, a strategy to selectively inhibit m-calpain may be useful for the therapeutic treatment of patients with atherosclerosis.
    PMID: 22064597 [PubMed - as supplied by publisher] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5424738</comments>
            <pubDate>Mon, 07 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5424738</guid>        </item>
        <item>
            <title>2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: Executive Summary: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions.</title>
            <link>http://www.medworm.com/index.php?rid=5424737&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22064598%26dopt%3DAbstract</link>
            <description>Authors: Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, Chambers CE, Ellis SG, Guyton RA, Hollenberg SM, Khot UN, Lange RA, Mauri L, Mehran R, Moussa ID, Mukherjee D, Nallamothu BK, Ting HH
    PMID: 22064598 [PubMed - as supplied by publisher] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5424737</comments>
            <pubDate>Mon, 07 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5424737</guid>        </item>
        <item>
            <title>2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.</title>
            <link>http://www.medworm.com/index.php?rid=5424736&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22064599%26dopt%3DAbstract</link>
            <description>Authors: Hillis LD, Smith PK, Anderson JL, Bittl JA, Bridges CR, Byrne JG, Cigarroa JE, Disesa VJ, Hiratzka LF, Hutter AM, Jessen ME, Keeley EC, Lahey SJ, Lange RA, London MJ, Mack MJ, Patel MR, Puskas JD, Sabik JF, Selnes O, Shahian DM, Trost JC, Winniford MD
    PMID: 22064599 [PubMed - as supplied by publisher] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5424736</comments>
            <pubDate>Mon, 07 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5424736</guid>        </item>
        <item>
            <title>2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: Executive Summary: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.</title>
            <link>http://www.medworm.com/index.php?rid=5424735&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22064600%26dopt%3DAbstract</link>
            <description>Authors: Hillis LD, Smith PK, Anderson JL, Bittl JA, Bridges CR, Byrne JG, Cigarroa JE, Disesa VJ, Hiratzka LF, Hutter AM, Jessen ME, Keeley EC, Lahey SJ, Lange RA, London MJ, Mack MJ, Patel MR, Puskas JD, Sabik JF, Selnes O, Shahian DM, Trost JC, Winniford MD
    PMID: 22064600 [PubMed - as supplied by publisher] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5424735</comments>
            <pubDate>Mon, 07 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5424735</guid>        </item>
        <item>
            <title>2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions.</title>
            <link>http://www.medworm.com/index.php?rid=5424734&amp;cid=s_36174_7_f&amp;fid=36174&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22064601%26dopt%3DAbstract</link>
            <description>Authors: Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, Chambers CE, Ellis SG, Guyton RA, Hollenberg SM, Khot UN, Lange RA, Mauri L, Mehran R, Moussa ID, Mukherjee D, Nallamothu BK, Ting HH
    PMID: 22064601 [PubMed - as supplied by publisher] (Source: Circulation)</description>
            <author>Circulation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5424734</comments>
            <pubDate>Mon, 07 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5424734</guid>        </item>
    </channel>
</rss>

